The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic cytotoxicity of histone deacetylase, poly-ADP ribose polymerase inhibitors and decitabine in breast and ovarian cancer cells: Therapeutic implications.
 
Apostolia Maria Tsimberidou
Consulting or Advisory Role - Avstera; BioEclipse Therapeutics; BrYet; Diaccurate; Macrogenics; Nex-I; Vincerx Pharma
Research Funding - Agenus (Inst); BrYet; IMMATICS (Inst); Novocure (Inst); OBI Pharma (Inst); Orionis (Inst); Parker Institute for Cancer Immunotherapy (Inst); Tachyon (Inst); Tempus (Inst); Tempus (Inst); Tvardi Therapeutics (Inst)
 
Benigno C. Valdez
No Relationships to Disclose
 
Bin Yuan
No Relationships to Disclose
 
Mehmet A. Baysal
No Relationships to Disclose
 
Abhijit Chakraborty
No Relationships to Disclose
 
Borje S. Andersson
No Relationships to Disclose